killerFLIP: A novel lytic peptide specifically inducing cancer cell death

Cell Death and Disease

Volumn 4, Issue 10, 2013, Pages

  Pennarun, B ^a   Gaidos, G ^b   Bucur, O ^a   Tinari, A ^c   Rupasinghe, C ^b   Jin, T ^a   Dewar, R ^a   Song, K ^a   Santos, M T ^a   Malorni, W ^c,d   Mierke, D ^b   Khosravi Far, R ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Dartmouth College   (United States)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^d San Raffaele Institute Sulmona   (Italy)

Author keywords

Amphiphilic; Death; Lysis; Peptide

Indexed keywords

ANTINEOPLASTIC AGENT; KILLERFLIP PEPTIDE; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; AQUEOUS SOLUTION; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER THERAPY; CELL DEATH; CELL MEMBRANE; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; ELECTRON MICROSCOPY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MICELLE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR XENOGRAFT; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CELL DEATH; CELL LINE, TUMOR; CELL SURVIVAL; HCT116 CELLS; HUMANS; MICROSCOPY, ELECTRON; PEPTIDES;

EID: 84887424060     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2013.401     Document Type: Article

References (76)

1. Alderton GK, Bordon Y. Tumour immunotherapy-leukocytes take up the fight. Nat Rev Immunol 2012; 12: 237
2. Pecot CV, Calin GA, Coleman RL, Lopez-Berestein G, Sood AK. RNA interference in the clinic: Challenges and future directions. Nat Rev Cancer 2011; 11: 59-67
3. Vander Heiden MG. Targeting cancer metabolism: A therapeutic window opens. Nat Rev Drug Discov 2011; 10: 671-684
4. Tu Z, Hao J, Kharidia R, Meng XG, Liang JF. Improved stability and selectivity of lytic peptides through self-assembly. Biochem Biophys Res Commun 2007; 361: 712-717
5. Papo N, Shai Y. New lytic peptides based on the D,L-amphipathic helix motif preferentially kill tumor cells compared to normal cells. Biochemistry 2003; 42: 9346-9354
6. Zhong J, Chau Y. Antitumor activity of a membrane lytic peptide cyclized with a linker sensitive to membrane type 1-matrix metalloproteinase. Mol Cancer Ther 2008; 7: 2933-2940
7. Stewart ML, Fire E, Keating AE, Walensky LD. The MCL-1 BH3 helix is an exclusive MCL-1 inhibitor and apoptosis sensitizer. Nat Chem Biol 2010; 6: 595-601
8. Rangel R, Guzman-Rojas L, le Roux LG, Staquicini FI, Hosoya H, Barbu EM et al. Combinatorial targeting and discovery of ligand-receptors in organelles of mammalian cells. Nat Commun 2012; 3: 788
9. Dartois V, Sanchez-Quesada J, Cabezas E, Chi E, Dubbelde C, Dunn C et al. Systemic antibacterial activity of novel synthetic cyclic peptides. Antimicrob Agents Chemother 2005; 49: 3302-3310
10. Lockshin RA, Zakeri Z. Cell death in health and disease. J Cell Mol Med 2007; 11: 1214-1224
11. Jin TG, Kurakin A, Benhaga N, Abe K, Mohseni M, Sandra F et al. Fas-associated protein with death domain (FADD)-independent recruitment of c-FLIPL to death receptor 5. J Biol Chem 2004; 279: 55594-55601
12. Ozturk S, Schleich K, Lavrik IN. Cellular FLICE-like inhibitory proteins (c-FLIPs): Fine-tuners of life and death decisions. Exp Cell Res 2012; 318: 1324-1331
13. Brooks H, Lebleu B, Vives E. Tat peptide-mediated cellular delivery: Back to basics. Adv Drug Delivery Rev 2005; 57: 559-577
14. Bechinger B, Lohner K. Detergent-like actions of linear amphipathic cationic antimicrobial peptides. Biochimica et biophysica acta 2006; 1758: 1529-1539
15. Hoskin DW, Ramamoorthy A. Studies on anticancer activities of antimicrobial peptides. Biochimica et biophysica acta 2008; 1778: 357-375
16. Teixeira V, Feio MJ, Bastos M. Role of lipids in the interaction of antimicrobial peptides with membranes. Prog Lipid Res 2012; 51: 149-177
17. Pennarun B, Meijer A, de Vries EG, Kleibeuker JH, Kruyt F, de Jong S. Playing the DISC: Turning on TRAIL death receptor-mediated apoptosis in cancer. Biochimica et biophysica acta 2010; 1805: 123-140
18. Day TW, Huang S, Safa AR. c-FLIP knockdown induces ligand-independent DR5-, FADD-, caspase-8-, and caspase-9-dependent apoptosis in breast cancer cells. Biochem Pharmacol 2008; 76: 1694-1704
19. Peter ME. Programmed cell death: Apoptosis meets necrosis. Nature 2011; 471: 310-312
20. Matsuzaki K. Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes. Biochimica et biophysica acta 1999; 1462: 1-10
21. Shai Y. Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochimica et biophysica acta 1999; 1462: 55-70
22. Sasisekharan R, Raman R, Prabhakar V. Glycomics approach to structure-function relationships of glycosaminoglycans. Annu Rev Biomed Engineering 2006; 8: 181-231
23. Rabenstein DL. Heparin and heparan sulfate: Structure and function. Natural Product Rep 2002; 19: 312-331
24. Kleeff J, Ishiwata T, Kumbasar A, Friess H, Buchler MW, Lander AD et al. The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer. J Clin Investig 1998; 102: 1662-1673
25. Matsuda K, Maruyama H, Guo F, Kleeff J, Itakura J, Matsumoto Y et al. Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells. Cancer Res 2001; 61: 5562-5569
26. Nakatsura T, Kageshita T, Ito S, Wakamatsu K, Monji M, Ikuta Y et al. Identification of glypican-3 as a novel tumor marker for melanoma. Clin Cancer Res 2004; 10: 6612-6621
27. Fadnes B, Rekdal O, Uhlin-Hansen L. The anticancer activity of lytic peptides is inhibited by heparan sulfate on the surface of the tumor cells. BMC Cancer 2009; 9: 183
28. Fadnes B, Uhlin-Hansen L, Lindin I, Rekdal O. Small lytic peptides escape the inhibitory effect of heparan sulfate on the surface of cancer cells. BMC Cancer 2011; 11: 116
29. Urbinati C, Nicoli S, Giacca M, David G, Fiorentini S, Caruso A et al. HIV-1 Tat and heparan sulfate proteoglycan interaction: A novel mechanism of lymphocyte adhesion and migration across the endothelium. Blood 2009; 114: 3335-3342
30. Hsu CC, Lin TW, Chang WW, Wu CY, Lo WH, Wang PH et al. Soyasaponin-I-modified invasive behavior of cancer by changing cell surface sialic acids. Gynecol Oncol 2005; 96: 415-422
31. Ulloa F, Real FX. Differential distribution of sialic acid in alpha2,3 and alpha2,6 linkages in the apical membrane of cultured epithelial cells and tissues. J Histochem Cytochem 2001; 49: 501-510
32. Schwartz MA. Integrins, oncogenes, and anchorage independence. J Cell Biol 1997; 139: 575-578
33. Dusek RL, Attardi LD. Desmosomes: New perpetrators in tumour suppression. Nat Rev Cancer 2011; 11: 317-323
34. Del Gaizo V, MacKenzie JA, Payne RM. Targeting proteins to mitochondria using TAT. Mol Genet Metabolism 2003; 80: 170-180
35. Tait SW, Green DR. Mitochondria and cell death: Outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol 2010; 11: 621-632
36. Fjell CD, Hiss JA, Hancock RE, Schneider G. Designing antimicrobial peptides: Form follows function. Nat Rev Drug Discov 2012; 11: 37-51
37. Song K, Benhaga N, Anderson RL, Khosravi-Far R. Transduction of tumor necrosis factorrelated apoptosis-inducing ligand into hematopoietic cells leads to inhibition of syngeneic tumor growth in vivo. Cancer Res 2006; 66: 6304-6311
38. Brown DA, Ward RL, Buckhaults P, Liu T, Romans KE, Hawkins NJ et al. MIC-1 serum level and genotype: Associations with progress and prognosis of colorectal carcinoma. Clin Cancer Res 2003; 9: 2642-2650
39. Brown DA, Lindmark F, Stattin P, Balter K, Adami HO, Zheng SL et al. Macrophage inhibitory cytokine 1: A new prognostic marker in prostate cancer. Clin Cancer Res 2009; 15: 6658-6664
40. Li PX, Wong J, Ayed A, Ngo D, Brade AM, Arrowsmith C et al. Placental transforming growth factor-beta is a downstream mediator of the growth arrest and apoptotic response of tumor cells to DNA damage and p53 overexpression. J Biol Chem 2000; 275: 20127-20135
41. Albertoni M, Shaw PH, Nozaki M, Godard S, Tenan M, Hamou MF et al. Anoxia induces macrophage inhibitory cytokine-1 (MIC-1) in glioblastoma cells independently of p53 and HIF-1. Oncogene 2002; 21: 4212-4219
42. Honore B. The rapidly expanding CREC protein family: Members, localization, function, and role in disease. Bio Essays 2009; 31: 262-277
43. Honore B, Vorum H. The CREC family, a novel family of multiple EF-hand, low-affinity Ca(2+)-binding proteins localised to the secretory pathway of mammalian cells. FEBS Lett 2000; 466: 11-18
44. Vorum H, Liu X, Madsen P, Rasmussen HH, Honore B. Molecular cloning of a cDNA encoding human calumenin, expression in Escherichia coli and analysis of its Ca2+-binding activity. Biochim Biophys Acta 1998; 1386: 121-131
45. Hseu MJ, Yen CH, Tzeng MC. Crocalbin: A new calcium-binding protein that is also a binding protein for crotoxin, a neurotoxic phospholipase A2. FEBS Lett 1999; 445: 440-444
46. Tsukumo Y, Tsukahara S, Saito S, Tsuruo T, Tomida A. A novel endoplasmic reticulum export signal: Proline at the +2-position from the signal peptide cleavage site. J Biol Chem 2009; 284: 27500-27510
47. Vorum H, Hager H, Christensen BM, Nielsen S, Honore B. Human calumenin localizes to the secretory pathway and is secreted to the medium. Exp Cell Res 1999; 248: 473-481
48. Wajih N, Sane DC, Hutson SM, Wallin R. The inhibitory effect of calumenin on the vitamin K-dependent gamma-carboxylation system. Characterization of the system in normal and warfarin-resistant rats. J Biol Chem 2004; 279: 25276-25283
49. Sahoo SK, Kim T, Kang GB, Lee JG, Eom SH, Kim do H. Characterization of calumenin- SERCA2 interaction in mouse cardiac sarcoplasmic reticulum. J Biol Chem 2009; 284: 31109-31121
50. Jung DH, Mo SH, DH Kim. Calumenin a multiple EF-hands Ca2+-binding protein, interacts with ryanodine receptor-1 in rabbit skeletal sarcoplasmic reticulum. Biochem Biophys Res Commun 2006; 343: 34-42
51. Conti E, Uy M, Leighton L, Blobel G, Kuriyan J. Crystallographic analysis of the recognition of a nuclear localization signal by the nuclear import factor karyopherin alpha. Cell 1998; 94: 193-204
52. Cook A, Bono F, Jinek M, Conti E. Structural biology of nucleocytoplasmic transport. Annu Rev Biochem 2007; 76: 647-671
53. Stewart M. Molecular mechanism of the nuclear protein import cycle. Nat Rev Mol Cell Biol 2007; 8: 195-208
54. Liu Q, Yu J, Zhuo X, Jiang Q, Zhang C. Pericentrin contains five NESs and an NLS essential for its nucleocytoplasmic trafficking during the cell cycle. Cell Res 2010; 20: 948-962
55. Fornerod M, Ohno M, Yoshida M, Mattaj IW. CRM1 is an export receptor for leucine-rich nuclear export signals. Cell 1997; 90: 1051-1060
56. Kudo N, Matsumori N, Taoka H, Fujiwara D, Schreiner EP, Wolff B et al. Leptomycin B inactivates CRM1/exportin 1 by covalent modification at a cysteine residue in the central conserved region. Proc Natl Acad Sci USA 1999; 96: 9112-9117
57. Ma RY, Tong TH, Cheung AM, Tsang AC, Leung WY, Yao KM. Raf/MEK/MAPK signaling stimulates the nuclear translocation and transactivating activity of FOXM1c. J Cell Sci 2005; 118(Pt 4): 795-806
58. Lidke DS, Huang F, Post JN, Rieger B, Wilsbacher J, Thomas JL et al. ERK nuclear translocation is dimerization-independent but controlled by the rate of phosphorylation. J Biol Chem 2010; 285: 3092-3102
59. Obenauer JC, Cantley LC, Yaffe MB. Scansite 2.0: Proteome-wide prediction of cell signaling interactions using short sequence motifs. Nucleic Acids Res 2003; 31: 3635-3641
60. Kinoshita E, Kinoshita-Kikuta E, Koike T. Separation and detection of large phosphoproteins using Phos-tag SDS-PAGE. Nat Protoc 2009; 4: 1513-1521
61. Sarno S, Reddy H, Meggio F, Ruzzene M, Davies SP, Donella-Deana A et al. Selectivity of 4,5,6,7-tetrabromobenzotriazole, an ATP site-directed inhibitor of protein kinase CK2 (casein kinase-2). FEBS Lett 2001; 496: 44-48
62. Chen ML, Liang LS, Wang XK. miR-200c inhibits invasion and migration in human colon cancer cells SW480/620 by targeting ZEB1. Clin Exp Metastasis 2012; 29: 457-469
63. Yehezkel G, Cohen L, Kliger A, Manor E, Khalaila I. O-linked beta-N-acetylglucosaminylation (O-GlcNAcylation) in primary and metastatic colorectal cancer clones and effect of N-acetyl-beta-D-glucosaminidase silencing on cell phenotype and transcriptome. J Biol Chem 2012; 287: 28755-28769
64. Kobayashi M, Aita N, Hayashi S, Okada K, Ohta T, Hirose S. DNA supercoiling factor localizes to puffs on polytene chromosomes in Drosophila melanogaster. Mol Cell Biol 1998; 18: 6737-6744
65. Panasyuk G, Nemazanyy I, Zhyvoloup A, Bretner M, Litchfield DW, Filonenko V et al. Nuclear export of S6K1 II is regulated by protein kinase CK2 phosphorylation at Ser-17. J Biol Chem 2006; 281: 31188-31201
66. Baek SJ, Kim JS, Moore SM, Lee SH, Martinez J, Eling TE. Cyclooxygenase inhibitors induce the expression of the tumor suppressor gene EGR-1, which results in the upregulation of NAG-1, an antitumorigenic protein. Mol Pharmacol 2005; 67: 356-364
67. Baek SJ, Horowitz JM, Eling TE. Molecular cloning and characterization of human nonsteroidal anti-inflammatory drug-activated gene promoter. Basal transcription is mediated by Sp1 and Sp3. J Biol Chem 2001; 276: 33384-33392
68. Shim M, Eling TE. Protein kinase C-dependent regulation of NAG-1/placental bone morphogenic protein/MIC-1 expression in LNCaP prostate carcinoma cells. J Biol Chem 2005; 280: 18636-18642
69. Frizzell KM, Gamble MJ, Berrocal JG, Zhang T, Krishnakumar R, Cen Y et al. Global analysis of transcriptional regulation by poly(ADP-ribose) polymerase-1 and poly(ADP-ribose) glycohydrolase in MCF-7 human breast cancer cells. J Biol Chem 2009; 284: 33926-33938
70. Krieg AJ, Rankin EB, Chan D, Razorenova O, Fernandez S, Giaccia AJ. Regulation of the histone demethylase JMJD1A by hypoxia-inducible factor 1 alpha enhances hypoxic gene expression and tumor growth. Mol Cell Biol 2010; 30: 344-353
71. Wang Q, Feng H, Zheng P, Shen B, Chen L, Liu L et al. The intracellular transport and secretion of calumenin-1/2 in living cells. PLoS One 2012; 7: E35344
72. Wang Q, Shen B, Zheng P, Feng H, Chen L, Zhang J et al. Silkworm coatomers and their role in tube expansion of posterior silkgland. PLoS One 2010; 5: E13252
73. Wang Q, Teng J, Shen B, Zhang W, Guo Y, Su X et al. Characterization of kinesin-like proteins in silkworm posterior silk gland cells. Cell Res 2010; 20: 713-727
74. Wang Q, Chen L, Shen B, Liu Y, Chen J, Teng J. The tau-like protein in silkworm (Bombyx mori) induces microtubule bundle formation. Front Biosci (Elite Ed) 2012; 4: 998-1008
75. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-408
76. Xie W, Ling T, Zhou Y, Feng W, Zhu Q, Stunnenberg HG et al. The chromatin remodeling complex NuRD establishes the poised state of rRNA genes characterized by bivalent histone modifications and altered nucleosome positions. Proc Natl Acad Sci USA 2012; 109: 8161-8166